Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05114980 · ClinicalTrials.gov registry record · NA

Parathyroid Allotransplantation in Medically Refractory Hypoparathyroidism

A NA study, sponsored by University of Alabama at Birmingham.

Not yet
Registry status
NA
Development phase
5
Enrollment target

NCT05114980: Clinical Trial NA study, sponsored by University of Alabama at Birmingham.

NCT05114980 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05114980, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.

NOT YET RECRUITING
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

Options for treatment of severe, refractory hypocalcemia are limited for the thousands of patients in the United States who suffer from hypoparathyroidism. Parathyroid allotransplantation is an emerging treatment that provides hope for these individuals. Currently, this therapy has only been successfully provided by a few centers in the world. In the UAB PATH trial, we propose to become one of the few centers worldwide to successfully achieve parathyroid allotransplantation in transplant-naïve patients.

Interventions

  • PROCEDURE Parathyroid Allotransplant

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2027-07
Est. Completion 2030-01
Phase NA
University of Alabama at Birmingham

1,160 total trials

What is known before NCT05114980 opens enrollment

NCT05114980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Parathyroid Allotransplant is the first listed.

NCT05114980 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05114980 about?

NCT05114980 is a clinical study titled "Parathyroid Allotransplantation in Medically Refractory Hypoparathyroidism". Options for treatment of severe, refractory hypocalcemia are limited for the thousands of patients in the United States who suffer from hypoparathyroidism. Parathyroid allotransplantation is an emerging treatment that provides hope for these individuals. Currently, this therapy has only been success...

What is the current status of trial NCT05114980?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2027-07. Estimated completion is 2030-01.

What interventions are being tested in trial NCT05114980?

The interventions under investigation include: Parathyroid Allotransplant (PROCEDURE).

Who is sponsoring clinical trial NCT05114980?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05114980's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT05114980, the US trial registry maintained by the National Library of Medicine. NCT05114980 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.